Most notably, in glioma, FKBP51 exhibits a unique context-dependent duality, potentially suppressing tumor growth via AKT inhibition while simultaneously promoting immune escape through regulation of PD-L1 expression. Here, FKBP4 is linked to central nervous system cancer.